NCT02363400 2025-08-19
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
Phase 3 Terminated
Clinical Trials
13 trialsNCT05914610 2023-08-25
Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer
Fujian Medical University
Phase 3 Not yet recruiting
NCT00207831 2020-03-25
UFT RT Phase 3
Institut Cancerologie de l'Ouest
Phase 3 Terminated
NCT04135781 2020-03-23
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage â…¢ Gastric Cancer
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT03941561 2019-05-31
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）
Fudan University
Phase 3 Recruiting
NCT03475615 2018-03-23
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
Fudan University
Phase 3 Unknown
NCT00392899 2016-09-28
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT00660894 2016-08-03
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT00385970 2012-10-26
A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Phase 3 Unknown
NCT01198392 2011-07-25
Trial of S-1 Plus Cisplatin in Gastric Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT00209742 2010-05-26
Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Unknown
NCT00497107 2008-07-31
ICOG
Iwate Medical University
Phase 3 Unknown
NCT00139971 2006-01-06
Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer
West Japan Thoracic Oncology Group
Phase 3 Unknown